-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

642. CLL: Therapy, excluding Transplantation: Poster II

CLL: Therapy, excluding Transplantation: Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Mohammed Farooqui, DO1, Janet Valdez, PA-C1*, Susan Soto, RN1*, Amanda Bray, RN1*, Xin Tian, PhD2* and Adrian Wiestner, MD, PhD1

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Petra Langerbeins, MD1*, Jasmin Bahlo2*, Christina Rhein1*, Paula Cramer, MD1*, Anna-Maria Fink, MD1*, Natali Pflug, MD1*, Julia von Tresckow, MD1*, Stephan Stilgenbauer, MD3, Karl-Anton Kreuzer1*, Michael J. Eckart, MD4*, Ursula Vehling-Kaiser, MD5*, Rudolf Schlag, MD6*, Christina Balser, MD7*, Lothar Müller, MD8*, Clemens-Martin Wendtner, MD9, Kirsten Fischer, MD1*, Barbara Eichhorst, MD1 and Michael Hallek, MD2

1Department I of Internal Medicine, University of Cologne, Cologne, Germany
2Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany
3Department of Internal Medicine III, University Hospital, Ulm, Germany
4Onkologische Schwerpunktpraxis Erlangen, Erlangen, Germany
5Oncology and palliative care, Dayclinic Landshut, Landshut, Germany
6Oncology, Practice for Oncology, Würzburg, Germany
7Oncology, Practice for Oncology, Marburg, Germany
8Oncology, Practice for Oncology, Leer, Germany
9Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Hospital Munich-Schwabing, Munich, Germany

Sameer A. Parikh, MD1, Kari Rabe Chaffee, MS2*, Timothy G. Call, MD1, Wei Ding, MD, PhD3, Jose F. Leis, MD, PhD4, Asher Chanan-Khan, MD5, Deborah A. Bowen, APRN, CNP1*, Michael Conte, PA-C1*, Daniel L. Van Dyke, PhD6, Curtis A. Hanson, MD6, Susan M. Schwager7*, Susan L. Slager, PhD8, Neil E. Kay, MD1 and Tait D. Shanafelt, MD9

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN
3Hematology/Oncology division, Mayo Clinic, Rochester, MN
4Department of Hematology, Mayo Clinic, Scottsdale, AZ
5Division of Hematology, Mayo Clinic, Jacksonville, FL
6Mayo Clinic, Rochester, MN
7Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
8Department of Health Sciences Research, Mayo Clinic, Rochester, MN
9Department of Hematology, Mayo Clinic, Rochester, MN

Asher Chanan-Khan, MD1, Paula Cramer, MD2*, Fatih Demirkan, MD3, Graeme Fraser, MD FRCPC4, Rodrigo Santucci Silva, MD5, Halyna Pylypenko, MD6*, Sebastian Grosicki, MD, PhD7, Ann Janssens, MD8*, Aleksander Pristupa, MD9*, Andre Goy, MD10, Jiri Mayer11, Marie Sarah Dilhuydy, MD12*, Javier Loscertales, MD, PhD13*, Nancy L. Bartlett, MD14, Abraham Avigdor, MD15, Simon Rule, MD16*, Steven Sun, PhD17*, Charles Phelps, MS17*, Michelle Mahler, MD17*, Mariya Salman, PhD17*, Angela Howes, PhD18 and Michael Hallek, MD19

1Division of Hematology, Mayo Clinic, Jacksonville, FL
2Department I of Internal Medicine, University of Cologne, Cologne, Germany
3Division of Hematology, Dokuz Eylul University, Izmir, Turkey
4Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
5Hemomed Oncologia e Hematologia, IEP São Lucas, São Paulo, Brazil
6Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine
7SPZOZ Zespol Szpitali Miejskich, Silesian Medical University in Katowice, Chorzów, Poland
8University Hospital Leuven, Leuven, Belgium
9Regional Clinical Hospital, Ryazan, Russia
10John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
11Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
12Hôpital Haut-Lévêque, Pessac, France
13Servicio de Hematología, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain
14Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
15Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Tel Aviv, Israel
16Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
17Janssen Research & Development, Raritan, NJ
18Janssen Research & Development, High Wycombe, United Kingdom
19Department of Internal Medicine, University of Cologne, Cologne, Germany

Mohammed Farooqui, DO1, Janet Valdez, PA-C1*, Susan Soto, RN1*, Maryalice Stetler-Stevenson, MD, PhD2, Constance M. Yuan, MD, PhD2*, Francine Thomas, BS3*, Xin Tian, PhD4*, Irina Maric5 and Adrian Wiestner, MD, PhD1

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Laboratory of Pathology, National Cancer Institute, Bethesda, MD
3National Institutes of Health, Radiology and Imaging Services, Clinical Research Center, Bethesda, MD
4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Hematology Section/Department of Laboratory Medicine, NIH/CCR, Bethesda, MD

Paula Cramer, MD1*, Asher Chanan-Khan, MD2, Graeme Fraser, MD FRCPC3, Fatih Demirkan, MD4, Rodrigo Santucci Silva, MD5, Halyna Pylypenko, MD6*, Sebastian Grosicki, MD, PhD7,8, Ann Janssens, MD9*, Andre Goy, MD10, Jiri Mayer11, Marie Sarah Dilhuydy, MD12*, Javier Loscertales, MD, PhD13*, Nancy L. Bartlett, MD14, Abraham Avigdor, MD15, Simon Rule, MD16*, Steven Sun, PhD17*, Charles Phelps, MS17*, Michelle Mahler, MD17*, Mariya Salman, PhD17*, Michael Schaffer, PhD18*, Sriram Balasubramanian, PhD18, Angela Howes, PhD19 and Michael Hallek, MD20

1Department I of Internal Medicine, University of Cologne, Cologne, Germany
2Division of Hematology, Mayo Clinic, Jacksonville, FL
3Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
4Division of Hematology, Dokuz Eylul University, Izmir, Turkey
5Hemomed Oncologia e Hematologia, IEP São Lucas, São Paulo, Brazil
6Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine
7SPZOZ Zespol Szpitali Miejskich, Silesian Medical University in Katowice, Chorzów, Poland
8Silesian Medical University, Katowice, Poland
9University Hospital Leuven, Leuven, Belgium
10John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
11Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
12Hôpital Haut-Lévêque, Pessac, France
13Servicio de Hematología, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain
14Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
15Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
16Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
17Janssen Research & Development, Raritan, NJ
18Janssen Research & Development, Springhouse, PA
19Janssen Research & Development, High Wycombe, United Kingdom
20Department of Internal Medicine, University of Cologne, Cologne, Germany

Constantine Tam, MBBS, MD1,2, Mary Ann Anderson, MBBS3,4, David S. Ritchie, MD, PhD5, E. Henry Januszewicz, MBBS6, Dennis Carney6*, Andrew W. Roberts, MBBS, PhD2,3,4 and John F. Seymour, MBBS, PhD2,6

1Peter MacCallum Cancer Centre, East Melbourne, Australia
2University of Melbourne, Melbourne, Australia
3Royal Melbourne Hospital, Melbourne, Australia
4Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
5Royal Melbourne Hospital, Parkville, Australia
6Peter MacCallum Cancer Centre, Melbourne, Australia

Meixiao Long, MD, PhD1, Kyle A. Beckwith, BS1*, Kami J. Maddocks, MD2, Carolyn Cheney, BS1*, Jennifer A. Woyach, MD2, Amy J. Johnson, PhD2, Natarajan Muthusamy, DVM, Ph.D.2 and John C. Byrd, MD2

1Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Javier Pinilla-Ibarz1*, Julio C Chavez, MD2, Elyce Turba, RN, MSN, OCN3*, Lisa Nodzon, PhD, ANP1*, Jennifer rock-Klotz, BA3*, Samir Dalia, MD4, Rami S. Komrokji, MD5, Frederick L. Locke, MD6, Mohamed A Kharfan-Dabaja, MD7 and Celeste M. Bello, MD8

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
3Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Mercy Clinic Oncology and Hematology, Joplin, MO
5Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
7Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Daruka Mahadevan, MD, PhD1, Emily K. Pauli, BMBS, PharmD2*, Kathy Cutter, RN, BSN2*, Lee Ann Dietz, RN1*, Peter Sportelli3, Hari P. Miskin, MS3* and Marshall T. Schreeder, MD2

1The West Clinic, University of Tennessee Health Sciences Center, Memphis, TN
2Clearview Cancer Institute, Huntsville, AL
3TG Therapeutics, Inc., New York, NY

Preetesh Jain, MBBS, MD, DM, PhD1*, Michael J. Keating, MD2, Charles Cleeland3*, Sarah Renner4*, Huang Xuelin5*, Graciela Nogueras Gonzalez6*, David M. Harris7*, William Wierda, MD, PhD8, Courtney DiNardo, MD9, Naveen Pemmaraju4*, Nitin Jain, MD2, Philip Thompson, MBBS2*, Alessandra Ferrajoli, MD2, Jan A. Burger, MD, PhD2, Hagop M. Kantarjian, MD2, Srdan Verstovsek, MD2 and Zeev Estrov, MD2

1Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Symptom Research, University of Texas, The MD Anderson Cancer Center, Houston
4Leukemia, University of Texas, The MD Anderson Cancer Center, Houston
5Biostatistics, University of Texas, The MD Anderson Cancer Center, Houston
6Biostatistics, University of Texas, The MD Anderson Cancer Center, Houston, TX
7The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
8Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
9University of Texas MD Anderson Cancer Center, Houston, TX

Peter Hillmen, MB, ChB, PhD1, Graeme Fraser, MD FRCPC2, Jeffrey Jones, MD, MPH3, Simon Rule, MD4*, Susan O'Brien, MD5, Marie Sarah Dilhuydy, MD6*, Ulrich Jaeger, MD7, Sebastian Grosicki, MD, PhD8, Florence Cymbalista, MD, PhD9, Steven Sun, PhD10*, Joi Ninomoto, PharmD11*, Michelle Mahler, MD10*, Mei Cheng, PhD11*, Joris Diels12*, Fong Clow, ScD11, Mariya Salman, PhD10*, Danelle F. James, MD, MAS11*, Angela Howes, PhD13 and Asher Chanan-Khan, MD14

1St. James University Hospital, Leeds, United Kingdom
2Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Hôpital Haut-Lévêque, Pessac, France
7Medical University of Vienna, Vienna, Austria
8Silesian Medical University, Katowice, Poland
9Hematology Biology, Hopital Avicenne, AP-HP, Bobigny, France
10Janssen Research & Development, Raritan, NJ
11Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
12Janssen EU HEMAR Statistics & Modeling, Beerse, Belgium
13Janssen Research & Development, High Wycombe, United Kingdom
14Division of Hematology, Mayo Clinic, Jacksonville, FL

Jose D Sandoval-Sus, MD1, Julio C Chavez, MD2, Samir Dalia, MD3, Celeste M. Bello, MD4, Bijal D. Shah, MD2, Viet Q. Ho, PharmD, RPh, BCOP2*, Lisa Nodzon, PhD, ANP5*, Mohamed A. Kharfan-Dabaja, M.D.6, Eduardo M. Sotomayor, MD7*, Lubomir Sokol, M.D, Ph.D.8 and Javier Pinilla-Ibarz5*

1Moffitt Cancer Center, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
3Mercy Clinic Oncology and Hematology, Joplin, MO
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
7Division of Hematology/Oncology, George Washington University Cancer Center, Washington, DC
8Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Francesca Romana Mauro, MD, PhD1*, Francesco Zaja2, Stefano Molica, MD3, Marta Coscia, MD, PhD4*, Anna Marina Liberati5, Alfonso Piciocchi6*, Fiorella Ilariucci, MD7*, Filomena Russo, MD8*, Francesca Re, MD8*, Alessandra Tedeschi, MD9,10*, Anna Baraldi, MD11*, Angelo Michele Carella12,13, Alessandro Gozzetti, MD14*, Giovanni Del Poeta, Pr, MD15, Agostino Cortelezzi, MD16, Roberta Battistini, MD17*, Emilia Iannella, MD1*, Antonietta Ferretti, MD1*, Ilaria Del Giudice, MD, PhD18*, Irene Della Starza, PhD1*, Sara Raponi, PhD1*, Maria Stefania De Propris, PhD1*, Caterina Ilari, PhD1*, Luciana Cafforio, PhD1*, Mauro Nanni, PhD1*, Paola Fazi6*, Marco Vignetti6*, Antonino Neri, Pr, MD19, Giorgina Specchia, Pr, MD20, Antonio Cuneo, Pr, MD21*, Anna Guarini22* and Robin Foà22*

1Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
2Chair of Hematology, DRMM, University of Udine, Udine, Italy
3Oncology/Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy
4Division of Hematology, A.O. Città della Salute e della Scienza di Torino, Turin, Italy
5S.C. Oncoematologia, A.O. S. Maria di Terni, Terni, Italy
6GIMEMA Data Center, Rome, Italy
7Department of Hematology, S. Maria Nuova Hospital, Reggio Emilia, Italy
8Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
9Division of Hematology, Niguarda Cà Granda Hospital, Milan, Italy
10Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
11Department of Hematology, SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy
12First Division of Hematology and Bone Marrow Transplantation, IRCCS AOU San Martino-IST, Genoa, Italy
13IRCCS Azienda Ospedaliera Universitaria San Martino-Ist, Genova, Italy
14Department of Hematology and Transplant, Le Scotte Hospital, Siena, Italy
15Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Roma, Italy
16Department of Clinical Sciences and Community Health, Hematology 1 CTMO, University of Milan, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Milan, Italy
17Department of Hematology, S. Camillo Hospital, Rome, Italy
18Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
19Department Medical Sciences, Hematology 1 CTMO, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
20Department of Emergency and Organ Transplantation, Section of Hematology with Transplantation, Medical Sch, University of Bari, Bari, Italy
21Department of Hematology, S. Anna Hospital, Ferrara, Italy
22Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy

Jonas Schmidt, MD1*, Julia Wild, MSc1*, Benedikt Strunz, MD1*, Lothar Kanz, MD2 and Helmut R Salih, MD1,2

1Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tuebingen, Tuebingen, Germany
2Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany

Anne Wanquet1*, Rudy Birsen2*, Sylvain Choquet, MD3*, Vincent Levy, MD, PhD4*, Jehan Dupuis, MD5*, Stephane Lepretre, MD6*, Daniel Re, MD7*, Jonathan Fahri8*, Mathilde Hunault, MD, PhD9*, Charlotte Bonnet10*, Anne-Sophie Michallet, MD11*, Loic Ysebaert, MD, PhD12*, Richard Lemal, MD13*, Thierry Lamy, MD, PhD14, Richard Delarue, MD15, Atchroue Johnson Ansah16*, Sylvain P Chantepie, MD17*, Xavier Troussard, MD, PhD18, Frederic Davi19*, Florence Cymbalista, MD, PhD20, Pierre-Yves Dietrich21*, Veronique Leblond, MD, PhD22* and Therese Aurran-Schleinitz, MD23*

1Hematology department, Institut Paoli Calmettes, Marseille, France
2Hopital Pitié Salpétrière, Paris, France
3Department of Clinical Hematology, Pitie-Salpetriere Hospital and Pierre et Marie Curie University, Paris, France
4URC/CRC, Hopital Avicenne, AP-HP, Bobigny, France
5Lymphoid Malignancies Unit, APHP, Groupe Hospitalier Mondor, CRETEIL, France
6Hematology, CLCC H Becquerel, Rouen, France
7Medecine 3, CH Antibes, Antibes, France
8CHU Angers, Angers, France
9Hematology Department, CHU, Angers, France
10CHU Bordeaux, Bordeaux, France
11CHU Lyon Sud-Pierre Bénite, Pierre-Benite, France
12CHU Purpan, Toulouse, France
13CHU Clermont Ferrand, Clermont Ferrand, France
14Haematology, CHU Pontchaillou, Rennes, France
15Hematology Department, AP-HP Hôpital Necker, Paris, France
16CHU Caen, Caen, France
17Department of Hematology, University Hospital, Caen, France
18CHU de Caen, Laboratoire d'hématologie, Caen, France
19Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France
20Hematology Biology, Hopital Avicenne, AP-HP, Bobigny, France
21CHU Genève, Geneve 14, Switzerland
22Department of Haematology, Hôpital de la Pitié-Salpétrière, Paris, France
23Hematology Department, Institut Paoli Calmettes, Marseille, France

Kaylin Marie McMahon1*, Cristina Scielzo2*, Lydia Scarfo3*, Pamela Ranghetti4*, Shuo Yang5*, Leo I. Gordon, MD6, Frank Giles, MD MB7*, Colby Shad Thaxton, MD, PhD1* and Paolo Ghia, MD, PhD8

1Northwestern University, Chicago
2IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milano, Italy
3Unit of Lymphoid Malignancies, Department of Onco-Hematology, San Raffaele Scientific Institute, Milan, Italy
4Università Vita-Salute San Raffaele and Università Vita-Salute San Raffaele and Ospedale San Raffaele, Milano, Italy
5Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago
6Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
7NMDTI, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
8Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milano, Italy

Tait D. Shanafelt, MD1, Kari G. Chaffee, MS2*, Timothy G. Call, MD1, Sameer A. Parikh, MD1, Susan M. Schwager3*, Wei Ding, MD, PhD1, Jose F. Leis, MD, PhD4, Asher Chanan-Khan, MD5, Susan L. Slager, PhD6 and Neil E. Kay, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Biomedical Statistics and Infomatics, Mayo Clinic, Rochester, MN
3Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
4Department of Hematology, Mayo Clinic, Scottsdale, AZ
5Division of Hematology, Mayo Clinic, Jacksonville, FL
6Department of Health Sciences Research, Mayo Clinic, Rochester, MN

Kerry A. Rogers, MD1, Galena Salem, MD1*, Deborah M. Stephens, DO2, Leslie A. Andritsos, MD3, Farrukh T. Awan, MD, MS3, John C. Byrd, MD3, Joseph M. Flynn, DO, MPH1, Kami J. Maddocks, MD3, Ying Huang, MA, MS1*, Amy S. Ruppert, MAS3* and Jeffrey A. Jones, MD, MPH1

1Division of Hematology, The Ohio State University, Columbus, OH
2Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Jennifer R. Brown, MD, PhD1*, Bruce D. Cheson, MD2, Richard R. Furman, MD3, Paolo Ghia, MD, PhD4, Michael Hallek, MD5, Peter Hillmen, MB, ChB, PhD6, Susan M. O'Brien, MD7*, Jeff P. Sharman, MD8, Ronald L. Dubowy, MD9, Barbara Velasco9*, Christopher C. Waldapfel9* and Andrew D. Zelenetz, MD, PhD10

1Dana-Farber Cancer Institute, Boston, MA
2Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
3New York-Presbyterian/Weill Cornell Medical Center, New York, NY
4Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milano, Italy
5Department of Internal Medicine, University of Cologne, Cologne, Germany
6Dept. of Haematology/Oncology, St. James's University Hospital, Leeds, United Kingdom
7University of California, Irvine/Chao Family Comprehensive Cancer Center, Orange, CA
8US Oncology Network/Willamette Valley Cancer Institute, Springfield, OR
9Gilead Sciences, Inc., Foster City, CA
10Memorial Sloan Kettering Cancer Center, New York, NY

Jennifer A. Woyach, MD1, Amy S. Ruppert, MAS1*, Farrukh Awan, MD, MS1, Jeffrey A. Jones, MD, MPH2, Sharon Waymer2*, Gerard Lozanski, MD3*, Natarajan Muthusamy, DVM, Ph.D.1 and John C. Byrd, MD1

1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3Division of Hematopathology, Department of Pathology, The Ohio State University, Columbus, OH

*signifies non-member of ASH